Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DPP9 encodes a protein that is a member of the S9B family in clan SC of the serine proteases. Additionally we are shipping DPP9 Kits (6) and DPP9 Proteins (4) and many more products for this protein.
Showing 10 out of 72 products:
Human Monoclonal DPP9 Primary Antibody for FACS, IF - ABIN2455302
Zhang, Chen, Wadham, McCaughan, Keane, Gorrell: Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin. in Biochimica et biophysica acta 2015
Human Monoclonal DPP9 Primary Antibody for WB - ABIN2455389
Huan, Jiang, Liu, Shen: Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors. in Journal of pharmacological and toxicological methods 2015
Properties of DPP9 are reported, including functional stability and sensitivity towards metal ions. The short form of DPP9 can be isolated from testes and it behaves as a stable enzyme.
The DPP9 expressing cell model system is a very useful and promising system for investigating the selectivity and associated toxicity of DPP4 (show DPP4 Antibodies) inhibitors on DPP9.
There was a concomitant decrease in the phosphorylation of focal adhesion kinase and paxillin (show PXN Antibodies), indicating that DPP9 knockdown or enzyme inhibition suppressed the associated adhesion signaling pathway, causing impaired cell movement.
Whereas DPP9-short is present in the cytosol, DPP9-long localizes preferentially to the nucleus.
The SUMO1 (show SUMO1 Antibodies)-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
Suggest roles for DPP8 (show DPP8 Antibodies) and DPP9 in lymphocyte activation and apoptosis and in hepatocytes during liver disease pathogenesis.
DPP9 was found in macrophages of carotid atherosclerotic plaque and may play a role in disease progression.
DPP9 binds to SUMO1 (show SUMO1 Antibodies) through a novel SUMO1 (show SUMO1 Antibodies) interacting motif.
this study demonstrates for the first time that DP8 (show DPP8 Antibodies) and DP9 are expressed in breast and ovarian carcinoma cell lines
Data identify modification points in the topology of a representative DPP8 (show DPP8 Antibodies)/9-inhibitor, capable of rendering selectivity for DPP8 (show DPP8 Antibodies) over DPP9.
These findings suggest an important signaling role of DPP9 in the regulation of survival and proliferation pathways.
DPP9 enzyme activity regulates metabolic pathways in neonatal liver and gut (show GUSB Antibodies).
Blocking the expression or activities of DPP8 (show DPP8 Antibodies) and DPP9 attenuates PPARgamma2 (show PPARG Antibodies) induction during preadipocyte differentiation.
Identification of novel dipeptidyl peptidase 9 substrates: discovering dipeptide Val-Ala as a consensus site for DPP9 cleavage
DPP9 enzymatic activity is essential for early neonatal survival in mice.
DP8 (show DPP8 Antibodies) and DP9 tissue and cellular expression
This gene encodes a protein that is a member of the S9B family in clan SC of the serine proteases. The protein has been shown to have post-proline dipeptidyl aminopeptidase activity, cleaving Xaa-Pro dipeptides from the N-termini of proteins. Although the activity of this protein is similar to that of dipeptidyl peptidase 4 (DPP4), it does not appear to be membrane bound. In general, dipeptidyl peptidases appear to be involved in the regulation of the activity of their substrates and have been linked to a variety of diseases including type 2 diabetes, obesity and cancer. Several transcript variants of this gene have been described but not fully characterized.
, DPP IX
, dipeptidyl peptidase 9
, dipeptidyl peptidase IV-related protein 2
, dipeptidyl peptidase IV-related protein-2
, dipeptidyl peptidase IX
, dipeptidyl peptidase-like protein 9
, dipeptidylpeptidase 9